Helix BioMedix, Inc. (HXBM)

Helix BioMedix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Mar 4, 2025	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Market Capitalization	2	12	14	9	9	13
Market Cap Growth	-8.00%	-8.71%	56.11%	-2.86%	-30.00%	-35.30%
Enterprise Value	-	10	21	13	10	11
Last Close Price	7.18	75.00	87.00	102.00	105.00	150.00
PS Ratio	0.78	6.57	15.99	22.29	15.95	27.65
PB Ratio	1.40	4.90	2.79	-1.69	-5.24	7.68
P/TBV Ratio	1.53	5.20	2.92	-	-	10.36
EV/Sales Ratio	-	5.48	24.81	33.09	18.12	23.33
Debt / Equity Ratio	-	-	-	-1.23	-2.32	-
Asset Turnover	0.81	0.46	0.24	0.17	0.24	0.18
Inventory Turnover	1.87	2.28	1.08	1.25	2.89	-
Quick Ratio	1.18	5.19	13.61	9.82	1.66	3.57
Current Ratio	2.33	6.23	14.69	11.48	1.84	4.17
Return on Equity (ROE)	-122.53%	-67.17%	-	-	-	-153.69%
Return on Assets (ROA)	-59.00%	-36.64%	-51.03%	-85.28%	-93.75%	-86.53%
Return on Capital (ROIC)	-71.83%	-40.56%	-61.16%	-117.51%	-112.84%	-98.42%
Earnings Yield	-160.14%	-20.02%	-56.63%	-43.28%	-50.29%	-26.77%
FCF Yield	-113.41%	-18.49%	-20.58%	-35.41%	-35.13%	-25.25%
Buyback Yield / Dilution	-10.06%	-83.31%	-5.73%	-	-2.04%	-12.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.